Natural killer cells gauge the absence of self class I MHC on susceptible target cells by means of inhibitory receptors such as members of the Ly49 family. To initiate killing by natural killer cells, a lack of inhibitory signals must be accompanied by the presence of activating ligands on the target cell. Although natural killer cell–mediated rejection of class I MHC–deficient bone marrow (BM) grafts is a matter of record, little is known about the targeting in vivo of specific cellular subsets by natural killer cells. We show here that development of class I MHC–negative thymocytes is delayed as a result of natural killer cell toxicity after grafting of a class I MHC–positive host with class I MHC–negative BM. Double positive thymocytes that persist in the presence of natural killer cells display an unusual T cell receptor–deficient phenotype, yet nevertheless give rise to single positive thymocytes and yield mature class I MHC–deficient lymphocytes that accumulate in the class I MHC–positive host. The resulting class I MHC–deficient CD8 T cells are functional and upon activation remain susceptible to natural killer cell toxicity in vivo. Reconstitution of class I MHC–deficient BM precursors with H2-Kb by retroviral transduction fully restores normal thymic development.
Skip Nav Destination
Article navigation
20 October 2003
Article|
October 20 2003
Elimination In Vivo of Developing T Cells by Natural Killer Cells
Eckart Schott,
Eckart Schott
Department of Pathology, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Roberto Bonasio,
Roberto Bonasio
Department of Pathology, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Hidde L. Ploegh
Hidde L. Ploegh
Department of Pathology, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Eckart Schott
Department of Pathology, Harvard Medical School, Boston, MA 02115
Roberto Bonasio
Department of Pathology, Harvard Medical School, Boston, MA 02115
Hidde L. Ploegh
Department of Pathology, Harvard Medical School, Boston, MA 02115
Address correspondence to Hidde L. Ploegh, Dept. of Pathology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-4777; Fax: (617) 432-4775; email: [email protected]
Abbreviations used in this paper: CFSE, 5,6-carboxyfluorescein-diacetate-succinimidyl-ester; DN, double negative; DP, double positive; lin, lineage; SP, single positive.
Received:
June 05 2003
Revision Received:
August 29 2003
Accepted:
September 09 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (8): 1213–1224.
Article history
Received:
June 05 2003
Revision Received:
August 29 2003
Accepted:
September 09 2003
Citation
Eckart Schott, Roberto Bonasio, Hidde L. Ploegh; Elimination In Vivo of Developing T Cells by Natural Killer Cells . J Exp Med 20 October 2003; 198 (8): 1213–1224. doi: https://doi.org/10.1084/jem.20030918
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement